论文部分内容阅读
赴美上市的亚洲化学药企中,先声药业曾创下融资规模最大一单,却又于去年年底黯然退市,先声药业董事长任晋生独家反思7年“美股之旅”:收购对医药企业并非捷径“后悔吗?”“已经退了,就谈不上后悔。”新浪旗下的乐居和微博两家公司同时于4月17日在美上市,这是属于中概股的新时刻。但这个时刻已经不属于任晋生,他控股的先声药业刚于去年年底在纽交所退市。我如此问坐在对面的任晋生,他则用温软的南通口音平静作答。
AMSC listed in the United States in the pharmaceutical industry, Simcere has hit the largest single largest financing, but sadly delisted at the end of last year, Ren Shengsheng Pharmaceutical chairman Ren exclusive review 7 years Acquisition of pharmaceutical companies is not a shortcut “regret it? ” “Has been back, will not regret it. ” Sina’s Le Ju and microblogging companies also listed on the United States on April 17, which is Belong to the new moment in the stock. But this moment does not belong to Ren Jinsheng, he controlled the initials just listed in the NYSE delisted last year. So I asked to sit opposite Ren Jinsheng, he used soft Nantong accent calm answer.